Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Diazepam nasal spray for acute repetitive seizures (China, Phase IV)
CTR20252685Phase 4Active
- Sponsor
- Neurelis
- Start
- Oct 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of diazepam in epilepsy, sponsored by Neurelis. Started Oct 2025; status: active.
02
Drugs
diazepam
03
Conditions
epilepsy
Beyond the preview
Go deeper on CTR20252685.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20252685.